
News
Filter Results
Displaying 1–10 of 517
-
Jun 18, 2025
José-Alain Sahel Awarded 2026 ARVO Proctor Medal for Groundbreaking Research Achievements
Dr. Sahel’s research has led to several emerging retinal disease therapies that have moved into clinical trials.
-
Jun 13, 2025
Jason Menzo Urges Robust FY2026 Funding for National Eye Institute and Protection of Its Independent Status.
-
Jun 13, 2025
Chairwoman Capito, Ranking Member Baldwin, and members of the Senate Appropriations Labor, Health and Human Services, Education, and Related Agencies Subcommittee, the Foundation Fighting Blindness appreciates the opportunity to provide written testimony to the subcommittee as an outside witness.
-
Jun 6, 2025
Patients have reported life-changing vision improvements after treatment in the Phase 3 LUMEOS trial.
-
Jun 4, 2025
Presentation Summaries from the 10th Annual Retinal Therapy Innovation Summit
In its tenth year, the Innovation Summit featured 28 presentations from industry professionals worldwide and more than 400 attendees.
-
May 15, 2025
ARVO 2025 Highlight: J&J’s XLRP Gene Therapy Didn’t Meet Primary Endpoint in Phase 3 Clinical Trial
Despite missing the primary endpoint, the treatment improved vision for some patients.
-
May 13, 2025
The company is planning a Phase 2/3 clinical trial for the therapy in late 2025.
-
May 12, 2025
Part B of the trial will enroll nine adult patients as well as three pediatric patients.
-
May 9, 2025
The company is currently enrolling patients in its Phase 2/3 VISTA Clinical Trial.
-
May 1, 2025
The Foundation Fighting Blindness develops strategic partnership with Alma, a network of 25,000 mental health professionals dedicated to simplifying access to high-quality, affordable mental healthcare.